* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn
* Graphic: World FX rates http://tmsnrt.rs/2egbfVh
By Ritvik Carvalho
LONDON, Jan 25 (Reuters) - Global shares rose to just shy of record highs, as optimism over a $1.9 trillion U.S. stimulus plan outweighed increasing COVID-19 cases and delays in vaccine supplies.
MSCI's All Country World index, which tracks stocks across 49 countries, was up 0.2% on the day. .MIWD00000PUS
E-mini futures for the S&P 500 gained 0.3%, indicating gains on Wall Street. ESc1 .N
Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.
A rally in U.S. tech stocks to near record highs on Friday helped fuel gains in their counterparts in Asia and Europe. A European basket of tech stocks gained 1.2% .SX8P . In Asia, Chinese tech giant Tencent soared 11% 0700.HK .
Investors are also wary about towering valuations amid questions over the efficiency of the vaccines in curbing the pandemic and as U.S. lawmakers continue to debate a coronavirus aid package. eyes are on Washington D.C. as U.S. lawmakers agreed that getting the COVID-19 vaccine to Americans should be a priority even as they locked horns over the size of the U.S. pandemic relief package. markets have been eyeing a massive package, though disagreements have meant months of indecision in a country suffering more than 175,000 COVID-19 cases a day with millions out of work.
Global COVID-19 cases are inching towards 100 million with more than 2 million dead. the recent outperformance in tech stocks, investors have reiterated views that cyclical and value stocks will outperform as economies recover.
"While renewed lockdowns and mobility restrictions around the world have supported 2020 stay-home beneficiaries, we do not think the rotation into cyclicals is over," said Mark Haefele, chief investment officer at UBS Global Wealth Management.
Haefele said a broadening economic recovery, a normalization of economic activity as vaccination programmes continue, and attractive valuations for emerging-market stocks relative to developed markets were reasons for UBS shifting its preference to emerging markets.
"Small/Mid (SMID) cap earnings were more impacted by the pandemic, and we project an earnings rebound more than 2x larger than the S&P 500," said BoFA strategists in a note.
"Historically, when Democrats control both the White House and Congress, SMID-cap returns have exceeded large cap. Also, SMID-caps are more domestically-oriented, which should benefit from on-shoring and infrastructure spending."
Sentiment in Asia was boosted by a report that China had surpassed the United States to be the largest recipient of foreign direct investment in 2020 with $163 billion in inflows. broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS rose 1.2% to 727.24, close to last week's record high of 727.31.
The benchmark is up nearly 9% so far in January, on track for its fourth straight monthly rise.
Japan's Nikkei .N225 rebounded from falls in early trading to be up 0.7%.
Australian shares .AXJO added 0.4% after the country's drug regulator approved the Pfizer/BioNTech COVID-19 vaccine with a phased rollout likely late next month. shares rose, with the blue-chip CSI300 index .CSI300 up 1%. Hong Kong's Hang Seng index .HSI leapt 2.4% led by technology stocks.
The dollar =USD traded flat against a basket of currencies at 90.228. Major currency trading pairs were trapped in a tight range as markets awaited the Federal Reserve's Wednesday meeting.
Gold rose 0.5% to $1,860 an ounce. XAU=
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global markets in 2021
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.